Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Multiple Sclerosis

Free Subscription 17.06.2024 1 Arch Phys Med Rehabil 3 J Neuroimmunol 5 J Neurol Sci 4 Mult Scler 2 Neurology 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Arch Phys Med Rehabil

1. KESSLER D, Franz M, Malakouti N, Rajachandrakumar R, et al
   A randomized control trial of occupational performance coaching for adults with multiple sclerosis.
   Arch Phys Med Rehabil. 2024 Jun 6:S0003-9993(24)01042.
   PubMed         Abstract available
   
   

   
   J Neuroimmunol

2. WHEELER D, Bezih M, Lannen N
   Spinocerebellar ataxia masquerading as multiple sclerosis, a case report.
   J Neuroimmunol. 2024;393:578385.
   PubMed        
   
   
3. YONG HYF, Batty NJ, Tottenham I, Koch M, et al
   Soluble adhesion molecules: Cognitive worsening biomarkers in primary progressive multiple sclerosis?
   J Neuroimmunol. 2024;393:578384.
   PubMed        
   
   
4. RECHTMAN A, Zveik O, Haham N, Brill L, et al
   A protective effect of lower MHC-II expression in MOGAD.
   J Neuroimmunol. 2024;391:578351.
   PubMed         Abstract available
   
   

   
   J Neurol Sci

5. HILDEBRANDT H, Eling P
   Comments on energy conservation treatments for MS-related fatigue and a new proposal.
   J Neurol Sci. 2024;461:123040.
   PubMed         Abstract available
   
   
6. TRIVEDI RR, Archambault AS, Pavlak C, Gastaldi M, et al
   Prevalence of anti-myelin oligodendrocyte glycoprotein antibodies across neuroinflammatory and neurodegenerative diseases.
   J Neurol Sci. 2024;461:123041.
   PubMed         Abstract available
   
   
7. FERNANDES L, Coats RO, Mon-Williams M, Hafeez A, et al
   A novel tool for characterising upper limb function in progressive multiple sclerosis through kinematic assessment.
   J Neurol Sci. 2024;462:123068.
   PubMed         Abstract available
   
   
8. MANNI A, Oggiano F, Palazzo C, Panetta V, et al
   Clinical and biological predictors of Cladribine effectiveness in Multiple Sclerosis: A real-world, single Centre study considering a two-year interval from year-2 dosing.
   J Neurol Sci. 2024;462:123070.
   PubMed         Abstract available
   
   
9. HELMLINGER B, Pinter D, Hechenberger S, Bachmaier G, et al
   Evaluation of the T25FW in minimally disabled people with multiple sclerosis.
   J Neurol Sci. 2024;462:123073.
   PubMed         Abstract available
   
   

   
   Mult Scler

10. KRIJNEN EA, Kouwenhoven RM, Noteboom S, Barkhof F, et al
    Subtypes and location of (juxta)cortical lesions relate to cognitive dysfunction in people with multiple sclerosis.
    Mult Scler. 2024 Jun 13:13524585241260968. doi: 10.1177/13524585241260968.
    PubMed         Abstract available
    
    
11. SMETS I, Versteegh M, Huygens S, Wokke B, et al
    Benefits of early highly effective versus escalation treatment strategies in relapsing multiple sclerosis estimated using a treatment-sequence model.
    Mult Scler. 2024 Jun 10:13524585241258692. doi: 10.1177/13524585241258692.
    PubMed         Abstract available
    
    
12. BORRELLI S, Guisset F, Vanden Bulcke C, Stolting A, et al
    Enlarged perivascular spaces are associated with brain microangiopathy and aging in multiple sclerosis.
    Mult Scler. 2024 Jun 7:13524585241256881. doi: 10.1177/13524585241256881.
    PubMed         Abstract available
    
    
13. PONZANO M, Signori A, Bellavia A, Carbone A, et al
    Race and ethnicity in multiple sclerosis phase 3 clinical trials: A systematic review.
    Mult Scler. 2024 Jun 7:13524585241254283. doi: 10.1177/13524585241254283.
    PubMed         Abstract available
    
    

    
    Neurology

14. PFEUFFER S, Wolff S, Aslan D, Rolfes L, et al
    Association of Clinical Relapses With Disease Outcomes in Multiple Sclerosis Patients Older Than 50 Years.
    Neurology. 2024;103:e209574.
    PubMed         Abstract available
    
    
15. MADSEN MA, Povazan M, Wiggermann V, Lundell H, et al
    Association of Cortical Lesions With Regional Glutamate, GABA, N-Acetylaspartate, and Myoinositol Levels in Patients With Multiple Sclerosis.
    Neurology. 2024;103:e209543.
    PubMed         Abstract available
    
    

    
    PLoS One

16. STEFANOVIC M, Jovanovic I, Zivkovic M, Stankovic A, et al
    Pathway analysis of peripheral blood CD8+ T cell transcriptome shows differential regulation of sphingolipid signaling in multiple sclerosis and glioblastoma.
    PLoS One. 2024;19:e0305042.
    PubMed         Abstract available
    
    
17. LI L, Zhang M, Gu M, Li J, et al
    The causal relationship between autoimmune diseases and age-related macular degeneration: A two-sample mendelian randomization study.
    PLoS One. 2024;19:e0303170.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.